Haleon plc Form 6-K Summary
Business context and reporting period
Haleon plc, an England and Wales–incorporated consumer healthcare company, filed a Form 6-K for November 2022. The filing, dated November 11, 2022, contains a UK Market Abuse Regulation disclosure of share transactions by two persons discharging managerial responsibilities under the company’s Share Reward Plan.
Financial and operating metrics
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating and financial performance metrics.
Material changes versus the prior comparable period
No period-over-period financial or operating comparison is provided. The filing reports the following transactions on November 9, 2022, on the London Stock Exchange:
| PDMR | Position | Transaction | Volume | Price |
|---|---|---|---|---|
| Bart Derde | Chief Supply Chain Officer | 44 partnership shares and 44 matching shares acquired | 88 ordinary shares | £2.82 per share |
| Jooyong Lee | Head of Strategy and Office of the CEO | 44 partnership shares and 44 matching shares acquired | 88 ordinary shares | £2.82 per share |
Guidance, outlook, risks, and unusual items
The filing provides no earnings guidance, outlook, management commentary, risk discussion, contingencies, or unusual financial items. The disclosed transactions are employee share-plan acquisitions and are not presented as open-market investment transactions.
Investor verification points
- Verify the transaction date of November 9, 2022 and filing date of November 11, 2022.
- Verify that each PDMR acquired 88 Haleon ordinary shares, comprising 44 partnership shares and 44 matching shares.
- Verify the reported price of £2.82 per share and the London Stock Exchange as the transaction venue.
- Verify that the filing contains no financial results or updated company guidance.